baber/WOPTO huggingface dataset:
Patent NZ-504525-A (NZ)
Title: Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis
Inventor: MEAKIN TIMOTHY DAVID
IPC: A61K31/21
Filed: 2000-05-12
Abstract: The use of a mixture of cetyl myristate and cetyl palmitate to treat eczema and/or psoriasis.
Patent NZ-504805-A (NZ)
Title: Compositions for weight reduction
Inventor: LUNDSGAARD JOERGEN SCHERNING
IPC: A23L1/30
Filed: 1998-12-04
Abstract: A composition that produces weight loss in a patient comprising two or more selected herbal extracts wherein at least one herbal extract inhibits gastric emptying and another different herbal extract increases metabolic rate in the patients so that weight loss is produced.
Patent NZ-507767-A (NZ)
Title: Cardboard box with triangular reinforced sides with outward protrusions on the side panels to increase stackability
Inventor: MUR GIMENO EMILIO
IPC: B65D5/20
Filed: 2000-10-25
Abstract: A cardboard box for perishable goods, in which a central sector (1) is a rectangular configuration, constitutive of the bottom box, which prolongs by means of four folding lines (2) into the end panels (3) and the side panels (4). The end panels (3) or the side panels (4) are of double walls. The internal wall (3') of the end panels, when they are of double wall, present some extensions with a double line of vertical fold, determining two sectors (5') and (5"). The first line to remain place in a diagonal respecting the dihedral corresponding to each corner of the box, while the second sector (5") of those extensions remain attached and fastened by means of gluing it to the internal surface of the corresponding side panel (4).
Patent NZ-511175-A (NZ)
Title: Method for viewing tumor tissue located within a body cavity
Inventor: LUIKEN GEORGE A
IPC: A61K49/00
Filed: 1999-10-12
Abstract: A  method  for in vivo detection of tissue  associated with  a  disease  state in a subject, such as  tumor  tissue located  in a body opening where the subject is administered a  biologically compatible fluorescing targeting  construct, the  construct is allowed to bind to and/or be taken  up  by diseased tissue present in the subject, a body part  of  the subject   suspected  of  containing  the  tumor  tissue   is irradiated in vivo with UV light while extraneous  light  to the  body part is substantially eliminated, and fluorescence emanating from the fluorescing targeting construct bound  to and/or  taken up by the tumor tissue is directly  viewed  by the observer with or without the aid of an endoscope, so  as to determine the location and size of the tumor tissue.
Patent NZ-517736-A (NZ)
Title: Sustained release drug delivery devices
IPC: A61K31/455
Filed: 2002-03-11
Abstract: A sustained release drug delivery system comprising an inner core or reservoir that has ganciclovir, a first coating layer essentially completely covering the inner core and being permeable to the passage of the ganciclovir, a second coating layer covering at least 50% of the inner core and being impermeable to the passage of the ganciclovir, said second layer comprising an impermeable film and a impermeable disc of a different material to the film, a third layer essentially completely covering the second layer and allowed controlled passage of the ganciclovir.
Patent NZ-517929-A (NZ)
Title: Immunostimulatory nucleic acids
Inventor: KRIEG ARTHUR M
IPC: A23L1/30
Filed: 2000-09-25
Abstract: Use of compounds comprising Py-rich immunostimulatory nucleic acid wherein the nucleic acid is a T-rich nucleic acid that is greater than 60% T and contains a CpG dinucleotide, for induction of immune response in subjects.
Patent NZ-521477-A (NZ)
Title: Tropane derivatives useful in therapy
Inventor: PERROS MANOUSSOS
IPC: A61P37/06
Filed: 2001-05-09
Abstract: A compound of formula I and the use of said compound for the manufacture of a medicament for the treatment of a respiratory disorder, HIV, an inflammatory disorder or a disorder in which the modulation of CCR5 receptors is implicated.
Patent NZ-522205-A (NZ)
Title: In situ recovery of hydrocarbons from a kerogen-containing formation
Inventor: BERCHENKO ILYA EMIL
IPC: C09K8/592
Filed: 2001-04-24
Abstract: A method for the in-situ pyrolysis of hydrocarbons in a subterranean kerogen-containing formation, comprising: providing heat to at least a portion of the kerogen-containing formation such that at least a part of the heated portion reaches the pyrolysis temperature of kerogen, yielding pyrolysis products; and collecting pyrolysis products from the subterranean formation; wherein the subterranean formation is selected to comprise kerogen with a vitrinite reflectance of 0.2 to 3.0%.
Patent NZ-529572-A (NZ)
Title: Pulmonary administration of chemically modified insulin
Inventor: PATTON JOHN S
IPC: A61K47/48
Filed: 2002-05-21
Abstract: Disclosed is an insulin composition for pulmonary administration, the composition comprising a conjugate of insulin covalently coupled to one or more molecules of a non-naturally occurring hydrophilic polymer, and preferably the conjugate is absent a lipophilic moiety. The above composition is used in a method for delivering insulin to a mammalian subject, by aerosolising the insulin composition and administering the aerosolised insulin composition by inhalation for deposition in and absorption by the lung of the subject.
Patent NZ-533359-A (NZ)
Title: Tool belt with provision to releasably secure tools in situ on the belt.
Inventor: LEMM JOHN RICHARD
IPC: F16B3/00
Filed: 2004-06-04
Abstract: A method of locking a tool to the belt of a user is disclosed. The tool is attached to a male pin 4, while a main pin 1 with a groove in its shaft is attached the user's belt via a stability plate. An outer casing 2 with a locating hole 3 is fitted to, and rotates about, the main pin 1. When the locating hole 3 is aligned with the groove in the main pin 1 the male pin 4 can be inserted. The male pin 4 also has a groove 14 to allow the casing 2 and pin 4 to be rotated while the pin is inserted. Once rotated the pin cannot be removed until the locating hole 3 and main pin groove are again aligned.
Patent NZ-534551-A (NZ)
Title: Water treament apparatus with bacterial culture medium
Inventor: MUSSON ANDREW PETER
Filed: 2004-08-06
Abstract: A water treatment apparatus includes a base platform 2, including many apertures 2a to allow water to flow through the platform, to be placed in the flow of water A to be treated, a layer 3 of a media suitable for hosting bacterial cultures covering a side of the base platform away from the water flow, and an electrified mesh layer 4 attached to the media layer on the side away from the base platform. In use the mesh layer is charged at an electrostatic negative voltage from a direct current power source so as to attract suspended solids in the wastewater and bond aerobic bacterial cultures to the media layer.
Patent NZ-536273-A (NZ)
Title: High dose ibandronate formulation
Inventor: KAESTLE HANS-G
IPC: A61K31/663
Filed: 2003-08-07
Abstract: Disclosed is a pharmaceutical composition for the treatment of bone diseases and disturbance of calcium metabolism, containing a disintegrant, a filler material and as active substance up to 250 mg of ibandronic acid or physiologically safe salts thereof for oral application, wherein the composition has been prepared by a granulation process including the step of adding the disintegrant in the granulate together with the active substance and with a part of the filler material.
Patent NZ-540126-A (NZ)
Title: Venting system for appliance
Inventor: MAUNSELL STEVE
Filed: 2005-05-17
Abstract: An appliance, such as a dishwasher, includes a sealable chamber, a door for the sealable chamber and a venting system for allowing air to escape from the chamber when the door is in a closed position. The venting system includes a vent flap 14 which forms part of a door and extends, in an open position, exteriorly of the door.
Patent NZ-541237-A (NZ)
Title: Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives for potassium channel regulation
Inventor: VRUDHULA VIVEKANANDA M
IPC: C07D215/22
Filed: 2003-12-18
Abstract: The present disclosure provides pharmaceutical compositions comprising the atropisomers of 3-substituted-4-arylquinolin-2-one derivatives, as in fig 1, substituents of which are as defined in the specification, and methods for the treatment of conditions sensitive to potassium channel opening activity such as ischemia, stroke, convulsions, epilepsy, asthma, irritable bowel syndrome, migraine, traumatic brain injury, spinal cord injury, sexual dysfunction and urinary incontinence.
Patent NZ-541303-A (NZ)
Title: Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
Inventor: GRAEBNER HAGEN
IPC: A61K31/46
Filed: 2003-12-04
Abstract: Disclosed is a capsule containing an inhalable powder containing tiotropium and salmeterol xinafoate, mixed with a physiologically acceptable excipient, wherein said capsule contains 8 to 12 mg of inhalable powder, and said salmeterol xinofoate has a melting point of about 124 deg C and is present in said inhalable powder in an amount from 0.363% by weight to 0.508% by weight.
Patent NZ-543258-A (NZ)
Title: Wood cutting tool
Inventor: FINOCCHIARO PIETRO
Filed: 2005-10-26
Abstract: A cutting tool for use with a lathe tp make a bowl shaped article from a work piece during a cutting operation, the cutting tool including a blade and a blade supporting means which has a region which is in contact with said blade and the region including a friction reducing means for reducing the frictional force experienced by the blade at the blade supporting means during the cutting operation
Patent NZ-544131-A (NZ)
Title: 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
Inventor: YASUHARA AKITO
IPC: A61P25/14
Filed: 2004-06-25
Abstract: Disclosed are compounds of formula [II], wherein X is fluorine, Y is 3-4-dichlorobenzyloxy, R2 is hydrogen and R1 is an alkyl group. The compounds are effective in treatments for and prevention of schizophrenia, anxiety, and psychiatric disorders such as depression, bipolar disorder, and epilepsy. The compounds have an antagonistic effect on the Group II metabotropic glutamate receptor.
Patent NZ-548613-A (NZ)
Title: Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
Inventor: CHEN BANG-CHI
IPC: C07C237/42
Filed: 2005-02-04
Abstract: Disclosed is a crystalline solvate of a 2-aminothiazole-5-aromatic carboxamides with formula (IV) which is characterized by its x-ray powder diffraction pattern, wherein the solvate is monohydrate, butanol or ethanol. Also disclosed is the pharmaceutical use of the compound for the treatment of cancer in particular chronic myelogenous leukemia (CML), gastrointestinal stromal tumor (GIST), small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), ovarian cancer, melanoma, mastocytosis, germ cell tumors, acute myelogenous leukemia (AML), pediatric sarcomas, breast cancer, colorectal cancer, pancreatic cancer, and prostate cancer. The process for preparing the crystalline solvate is also disclosed.
Patent NZ-548863-A (NZ)
Title: New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
Inventor: COQUEREL GERARD
IPC: A61K31/165
Filed: 2006-08-01
Abstract: Crystalline form IV of agomelatine (N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide) is disclosed, wherein the crystalline form IV of agomelatine has powder X-ray diffraction diagram, measured using a diffractometer (copper anticathode) and expressed in terms of inter-planar distance d (17.524-3.190 A[deg]), Bragg's angle 2 theta (5.04-27.95 degree), intensity and relative intensity (expressed as a percentage with respect to the most intense ray). A process for the preparation of the crystalline form IV of agomelatine is disclosed, wherein agomelatine is heated at 110[deg.] C. until completely melted, is then rapidly cooled between 50 and 70[deg.] C, and is maintained for about 5 hours at 70[deg.] C until crystallisation occurs. A pharmaceutical composition comprising as active ingredient an effective amount of crystalline form IV of agomelatine is suitable for treating sleep disorders, stress, anxiety, seasonal affective disorders or severe depression, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue due to jetlag, schizophrenia, panic attacks, melancholia, appetite disorders, obesity, insomnia, psychotic disorders, epilepsy, diabetes, Parkinson's disease, senile dementia, various disorders associated with normal or pathological ageing, migraine, memory loss, Alzheimer's disease, cerebral circulation disorders, and also in sexual dysfunction, as ovulation inhibitors, immunomodulators and cancers.
Patent NZ-550210-A (NZ)
Title: A locating device
Inventor: GARLAND ANTHONY RALPH
Filed: 2006-09-27
Abstract: Disclosed is a locating device which is configured to attach to an anchor line, a dispenser configured to cooperate with a locating device on an anchor line, and a method for dispensing a material into a body of water, using a dispenser configured to cooperate with a locating device attached on an anchor line, at a predetermined position from the anchored end of the anchor line. The method for dispensing material into a body of water includes the steps of: a) placing material to be dispensed into the dispenser; b) connecting the dispenser to the anchor line at a position further from the anchored end than the attached position of the locating device, and c) releasing the dispenser so that it slides along the anchor line until it engages with the locating device.
Patent NZ-562244-A (NZ)
Title: Heaters with exposed metal sections, which are coupled by materials to facilitate connection when melted and cooled or when exploded
Inventor: BASS RONALD MARSHALL
IPC: E21B36/04
Filed: 2006-04-21
Abstract: A system for heating a subsurface formation is disclosed. The system includes a first elongated heater in a first opening in the formation and a second elongated heater in a second opening in the formation. The first elongated heater includes an exposed metal section in a portion of the first opening, which is below a layer of the formation to be heated, with the exposed metal section being exposed to the formation. The second elongated heater in a second opening in the formation, which connects to the first opening at or near the portion of the first opening below the layer to be heated. The system further includes an electrical coupling, which couples at least a portion of an exposed metal section of the second elongated heater to at least a portion of the exposed metal section of the first elongated heater in the portion of the first opening below the layer to be heated. The electrical coupling comprises a container configured to be coupled to an end portion of at least one of the heaters. The end portion is below the layer to be heated. The container comprises an electrical coupling material configured to facilitate, when melted and then cooled, an electrical connection between the first elongated heater and the second elongated heater. The electrical coupling may alternatively comprise an explosive element configured to be coupled to an end portion of at least one of the heaters. The end portion is below the layer to be heated, and the explosive element is configured to facilitate, when exploded, an electrical connection between the first elongated heater and the second elongated heater.
Patent NZ-562276-A (NZ)
Title: A tourniquet of strip form with latching elements passing through aperture and configured to bend towards the strip
Inventor: DAVIES IAIN
IPC: A61B17/132
Filed: 2006-03-16
Abstract: A tourniquet (102) comprising a strip formed of sheet material having a first end and a second end, said strip defining an aperture (401) towards said first end and having a portion adjacent the second end configured to pass through said aperture. The tourniquet has a plurality of latching elements (404) spaced along said portion, wherein said latching elements extend from said portion and are configured to allow said portion to pass through said aperture and to provide resistance to said portion passing out of said aperture. The latching elements are configured to bend towards the surface of the strip when the tourniquet is in use.
Patent NZ-567800-A (NZ)
Title: Seamless inter-frequency handoff in wireless communication networks
Inventor: ULUPINAR FATIH
IPC: H04W36/06
Filed: 2006-10-27
Abstract: A method for seamless inter-frequency handoff in a wireless network is disclosed. The method includes the steps of: reporting to an access network a sector pilot strength information for a first frequency member in a message specified in an active set management protocol; receiving information about a second frequency member in a message specified in the active set management protocol, where the first frequency member is operating at a different frequency than the second frequency member; ascertaining whether to handoff from the first frequency member to the second frequency member, where both the first and the second frequency members are included in the active set; and seamlessly handing off to the second frequency member.
Patent NZ-569901-A (NZ)
Title: Side handles for a carton
Inventor: SPIVEY RAYMOND RUDOLPH
IPC: B65D5/46
Filed: 2007-01-25
Abstract: A carton is disclosed comprising of a plurality of panels. The carton includes a first panel, the first panel disposed between a second panel and a third panel. A first end flap is also included, foldably connected to the first panel, with the first end flap at least partially defining a handle opening. The carton further comprises a second end flap which is foldably connected to the second panel and at least a third end flap foldably connected to the third panel. The second end flap includes a second end flap reinforcement panel and a second end flap remainder portion separated by a second end flap tear line. The third end flap includes a third end flap reinforcement panel and a third end flap remainder portion separated by a third end flap tear line. Upon formation of the carton, the second end flap reinforcement panel and the third end flap reinforcement panel are separated along the second end flap tear line and the third end flap tear line, respectively, and are folded in an overlapping relationship with at least a portion of the first end flap. the second end flap reinforcement panel and the third end flap reinforcement panel are proximate the handle opening.
Patent NZ-570357-A (NZ)
Title: Liquid fuel container delivery system with manually operated liquid pump and double tube flexible hose for liquid supply and suction vapour recovery
Inventor: BONNER MARK A
IPC: B67D7/04
Filed: 2007-01-09
Abstract: A portable fuel delivery system for supplying liquid fuel to a remote destination including a portable liquid fuel container supplying fluid; a manually operable integrally-formed two channel hose assembly consisting of a flexible delivery hose for supplying liquid to a remote destination, a flexible vapour recovery tube or conduit for recovering fuel vapour from the remote destination and a nozzle or spout with a handle; and a hand operated fluid or liquid pump that initiates liquid flow from the container to the remote destination, and fuel vapour is drawn or sucked back to the portable fuel container through the vapour line under educed pressure.
Patent NZ-571569-A (NZ)
Title: Pharmaceutical compositions comprising anti miRNA antisense oligonucleotides
Inventor: ELMEN JOACIM
IPC: C12N15/113
Filed: 2007-03-30
Abstract: Disclosed is a single-stranded oligonucleotide 8 to 24 nucleotides in length capable of reducing an effective amount of a miRNA in vitro or in a non-human cell or non-human organism, wherein said single stranded oligonucleotide comprises: (i) a sequence that is complementary to a sequence of said miRNA; (ii) a sequence comprising not more than 4 consecutive 2'-deoxyribose nucleoside (DNA) units and not more than 4 consecutive Locked Nucleic Acid (LNA) units; (iii) at least 30% of constituent nucleotides as LNA units; and (iv) at least one internucleosidelinkage group comprising a phosphorothioate, subject to the proviso that the single-stranded oligonucleotide does not comprise a core DNA sequence of 3'-ctcaca- 5' from positions two to seven or from positions three to eight thereof counting from the 3' end of said oligonucleotide.
Patent NZ-572490-A (NZ)
Title: Guide arrangement for the handling elements of a wood object, such as a log
Inventor: ISSUKKA SEPPO
Filed: 2008-11-03
Abstract: Guide arrangement for the handling elements 1, more particularly for the rotators/aligners, of a wood object, such as a log 4, for guiding the control elements 2, such as hydraulic leads, electrical leads and/or pneumatic leads, fitted to the handling elements, wherein the control elements are fixed to the rotatable frame piece 3 of the handling element, into which frame piece the logs 4 can be fed, and in that the guide arrangement comprises at least one guide element 5 guiding the control elements, which is fitted to pass via at least one guide part 6 as well as rotatable frame piece of the handling element, and in that the control elements are fitted to the guide element to control and/or to compensate the movement of the control elements.
Patent NZ-573142-A (NZ)
Title: Improved bolus
Inventor: LEECH WAYNE FREDERICK
IPC: A61D7/00
Filed: 2008-11-25
Abstract: A bolus for administration to a ruminant by deposition into its rumen, the bolus having a construction including: a) a casing; b) a core inside the casing wherein the core is formed from at least two tablets; and, characterised in that a permanently amorphous substance at least partially coats one or more of the tablet or tablets. The permanently amorphous substance may be an oil based substance such as petroleum jelly or liquid paraffin. The casing may be coated with a water impermeable material. The casing may be of metal alloy, with the tablets of the core containing electrically conductive material lower in the electrochemical series than the constituents of the metal alloy casing.
Patent NZ-573622-A (NZ)
Title: Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
Inventor: KINZLER MATTHIAS
IPC: C12N15/117
Filed: 2007-06-12
Abstract: Disclosed is a process for producing a nucleotide composition comprising an oligonucleotide, said process comprising the steps of: a) providing an oligonucleotide in solution I, wherein said oligonucleotide comprises at least one poly G stretch; and wherein said solution I comprises an alkaline pH; b) disaggregating said oligonucleotide, wherein said disaggregating comprises the steps of: i. adjusting the temperature of solution I to temperature I, wherein said temperature I is 4 to 70 degrees Celsius; ii. incubating said oligonucleotide in said solution I at said temperature I, wherein said incubating is performed until said oligonucleotide comprises a relative peak start time above 110 %; and iii. adjusting the temperature of said solution I to temperature II, wherein said temperature II is 0 to 70 degrees Celsius; c) adjusting the pH of said solution I to pH 5 to 8; and d) aggregating said oligonucleotide, wherein said aggregating comprises the steps of: i. providing said oligonucleotide in solution II, wherein said solution II comprises pH 5 to 8 and at least 20 mM of a cation, wherein said cation is selected from the group consisting of Na+, K+, NH/, Lt, Ca2+, and Mg2+; ii. adjusting the temperature of solution II to temperature III, wherein said temperature III is 50 to 99 degrees Celsius; iii. incubating said oligonucleotide in solution II at temperature III, wherein said incubating is performed until said oligonucleotide comprises a relative peak start time of 50 to 110 %; and iv. adjusting the temperature of solution II to temperature IV, wherein said temperature IV is below 50 degrees Celsius.